Chapel Down Group And 2 Other UK Penny Stocks To Watch
In This Article:
The UK market has recently faced challenges, with the FTSE 100 and FTSE 250 indices experiencing declines due to weak trade data from China, highlighting global economic interdependencies. Amid such fluctuations, investors often seek opportunities in lesser-known areas of the market where potential growth can be found. Penny stocks, though an outdated term, still represent a segment where smaller or newer companies might offer unique value propositions backed by strong financials.
Top 10 Penny Stocks In The United Kingdom
| Name | Share Price | Market Cap | Financial Health Rating |
| Polar Capital Holdings (AIM:POLR) | ￡4.85 | ￡467.47M | ★★★★★★ |
| ME Group International (LSE:MEGP) | ￡2.20 | ￡828.88M | ★★★★★★ |
| Supreme (AIM:SUP) | ￡1.74 | ￡202.9M | ★★★★★★ |
| FRP Advisory Group (AIM:FRP) | ￡1.415 | ￡347M | ★★★★★★ |
| Next 15 Group (AIM:NFG) | ￡3.9644 | ￡394.28M | ★★★★☆☆ |
| Stelrad Group (LSE:SRAD) | ￡1.48 | ￡188.48M | ★★★★★☆ |
| Luceco (LSE:LUCE) | ￡1.328 | ￡204.82M | ★★★★★☆ |
| Tristel (AIM:TSTL) | ￡4.20 | ￡200.13M | ★★★★★★ |
| Character Group (AIM:CCT) | ￡2.80 | ￡52.57M | ★★★★★★ |
| Integrated Diagnostics Holdings (LSE:IDHC) | $0.4745 | $275.84M | ★★★★★★ |
Click here to see the full list of 471 stocks from our UK Penny Stocks screener.
Here's a peek at a few of the choices from the screener.
Chapel Down Group
Simply Wall St Financial Health Rating: ★★★★☆☆
Overview: Chapel Down Group Plc, with a market cap of ￡66.89 million, is involved in the production and sale of alcoholic beverages both in the United Kingdom and internationally through its subsidiaries.
Operations: The company's revenue is derived from the production and sale of alcoholic beverages, amounting to ￡16.28 million.
Market Cap: ￡66.89M
Chapel Down Group Plc, with a market cap of ￡66.89 million, is experiencing significant volatility and remains unprofitable despite reducing losses over the past five years. The company has a strong brand presence in English wine, with 42% awareness and substantial distribution channels. Recent strategic reviews concluded no superior alternatives to remaining independent, highlighting confidence in the English wine industry's growth potential. However, revenue for H1 2024 decreased to ￡7.12 million from ￡8.04 million year-on-year, reflecting operational challenges amid leadership changes as CEO Andrew Carter steps down by mid-2025 after boosting market capitalisation during his tenure.
Diaceutics
Simply Wall St Financial Health Rating: ★★★★★★
Overview: Diaceutics PLC is a diagnostic commercialisation company offering data, data analytics, and implementation services to pharmaceutical companies globally, with a market cap of ￡102.64 million.